Int J Stomatol

Int J Stomatol ›› 2019, Vol. 46 ›› Issue (6): 711-717.doi: 10.7518/gjkq.2019101

• Reviews • Previous Articles     Next Articles

Research progress on the evaluation and management of radiation-induced xerostomia

Chen Dong,Yang Zheng,Jiang Li()   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of General Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2019-03-09 Revised:2019-07-15 Online:2019-11-01 Published:2019-11-14
  • Contact: Li Jiang E-mail:echojiang999@gmail.com

RichHTML

14

PDF (PC)

488

Abstract:

Radiation-induced xerostomia is a common complication after radiotherapy for head and neck cancer. It significantly affects quality of life in survivors of head and neck cancer. In this review, the evaluations of xerostomia including saliva secretion function, imaging examinations and subjective measurements were discussed, as well as the management before, during and after radiotherapy. They provided evidence and approach for reducing morbidity of xerostomia and increasing quality of life in patients under radiotherapy.

Key words: head and neck neoplasms, radiotherapy, xerostomia, salivary glands, quality of life

CLC Number: 

  • R730.55

TrendMD: 

Tab 1

RTOG/EORTC grading system"

分级 急性腺体损伤 晚期腺体损伤
0 无改变 无改变
Ⅰ 轻微口干,唾液略微变稠,轻度味觉稍改变如金属味,这些改变不影响进食习惯如餐中饮水增加 弥散性红斑,轻微口干,唾液略微变稠,轻度味觉稍改变如金属味,进食习惯改变如餐中饮水增加
Ⅱ 中等至完全口干,黏稠的唾液,显著味觉改变 小型溃疡,中等至完全口干,唾液黏稠
Ⅲ - 半数以上口腔黏膜疼痛性溃疡和/或急性唾液腺坏死
Ⅳ 急性唾液腺坏死 纤维化

Tab 2

LENT/SOMA criteria"

项目 1级 2级 3级 4级
主观（S） 偶尔口干 部分但能忍受口干 完全口干,身体未衰弱 完全口干,身体衰弱
客观（O） 正常湿润唾液 唾液缺乏湿润 无湿润,黏稠的唾液 无湿润,被覆黏膜的唾液
管理（M） - 偶尔使用人工唾液、口香糖或增唾液药物 经常使用人工唾液或喝水、口香糖或增唾液药物 完全需要人工唾液或喝水来进食、使用口香糖或增唾液药物
数据分析（A） SFR为术前76%~95% SFR为术前51%~75% SFR为术前26%~50% SFR为术前0~25%
[1] Pinna R, Campus G, Cumbo E , et al. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage[J]. Ther Clin Risk Manag, 2015,11:171-188.
[2] Wijers OB, Levendag PC, Braaksma MM , et al. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long- term survivors[J]. Head Neck, 2002,24(8):737-747.
[3] Rubira CM, Devides NJ, Ubeda LT , et al. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors[J]. Braz Oral Res, 2007,21(3):272-277.
[4] Yang X, Tridandapani S, Beitler JJ , et al. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy[J]. Acad Radiol, 2014,21(10):1304-1313.
[5] de Castro G Jr, Federico MH . Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients[J]. Curr Opin Oncol, 2006,18(3):266-270.
[6] Dirix P, Nuyts S, Vander Poorten V , et al. The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer[J]. Support Care Cancer, 2008,16(2):171-179.
[7] Gensheimer MF, Liao JJ, Garden AS , et al. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes[J]. Radiat Oncol, 2014,9:255.
[8] Lee SW, Kang KW, Wu HG . Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era[J]. Head Neck, 2016,38(Suppl 1):E1746-E1755.
[9] Sullivan CA, Haddad RI, Tishler RB , et al. Chemoradiation-induced cell loss in human submandibular glands[J]. Laryngoscope, 2005,115(6):958-964.
[10] Sønstevold T, Johannessen AC, Stuhr L . A rat model of radiation injury in the mandibular area[J]. Radiat Oncol, 2015,10:129.
[11] Gupta T, Hotwani C, Kannan S , et al. Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose-response relationship of parotid-sparing radiotherapy in head-neck cancers[J]. Radiat Oncol, 2015,10:67.
[12] Dirix P, Nuyts S , Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review[J]. Cancer, 2006,107(11):2525-2534.
[13] Fujimaki Y, Tsunoda K, Ishimoto S , et al. Non-invasive objective evaluation of radiotherapy-induced dry mouth[J]. J Oral Pathol Med, 2014,43(2):97-102.
[14] Palma LF, Gonnelli FAS, Marcucci M , et al. A novel method to evaluate salivary flow rates of head and neck cancer patients after radiotherapy: a pilot study[J]. Braz J Otorhinolaryngol, 2018,84(2):227-231.
[15] Lee TF, Chao PJ, Wang HY , et al. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments[J]. BMC Cancer, 2012,12:567.
[16] Wada A, Uchida N, Yokokawa M , et al. Radiation-induced xerostomia: objective evaluation of salivary gland injury using MR sialography[J]. AJNR Am J Neuroradiol, 2009,30(1):53-58.
[17] Houweling AC, van den Berg CA, Roesink JM , et al. Magnetic resonance imaging at 3.0T for submandibular gland sparing radiotherapy[J]. Radiother Oncol, 2010,97(2):239-243.
[18] Loimu V, Seppälä T, Kapanen M , et al. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy[J]. Radiother Oncol, 2017,122(2):178-184.
[19] Zhou N, Chu C, Dou X , et al. Early changes of irradiated parotid glands evaluated by T1rho-weighted imaging: a pilot study[J]. J Comput Assist Tomogr, 2017,41(3):472-476.
[20] Yang X, Tridandapani S, Beitler JJ , et al. Ultrasound histogram assessment of parotid gland injury following head-and-neck radiotherapy: a feasibility study[J]. Ultrasound Med Biol, 2012,38(9):1514-1521.
[21] Yang X, Tridandapani S, Beitler JJ , et al. Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity[J]. Med Phys, 2012,39(9):5732-5739.
[22] van Dijk LV, Brouwer CL, van der Laan HP , et al. Geometric image biomarker changes of the parotid gland are associated with late xerostomia[J]. Int J Radiat Oncol Biol Phys, 2017,99(5):1101-1110.
[23] van Dijk LV, Noordzij W, Brouwer CL , et al. 18F- FDG PET image biomarkers improve prediction of late radiation-induced xerostomia [J]. Radiother Oncol, 2018,126(1):89-95.
[24] Nardone V, Tini P, Nioche C , et al. Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT[J]. Radiol Med, 2018,123(6):415-423.
[25] Karbach J, Walter C, Al-Nawas B . Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation[J]. Clin Oral Investig, 2012,16(4):1305-1312.
[26] Beetz I, Burlage FR, Bijl HP , et al. The groningen radiotherapy-induced xerostomia questionnaire: development and validation of a new questionnaire[J]. Radiother Oncol, 2010,97(1):127-131.
[27] Memtsa PT, Tolia M, Tzitzikas I , et al. Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients[J]. Support Care Cancer, 2017,25(3):847-853.
[28] MD Anderson Head and Neck Cancer Symptom Working Group, Kamal M, Rosenthal DI , et al. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors[J]. Radiother Oncol, 2018,126(1):75-80.
[29] Brody S, Omer O, McLoughlin J, et al. The dentist’s role within the multi-disciplinary team maintaining quality of life for oral cancer patients in light of recent advances in radiotherapy[J]. J Ir Dent Assoc, 2013,59(3):137-146.
[30] Levi LE, Lalla RV . Dental treatment planning for the patient with oral cancer[J]. Dent Clin North Am, 2018,62(1):121-130.
[31] Sood AJ, Fox NF, O’Connell BP, et al. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis[J]. Oral Oncol, 2014,50(2):77-83.
[32] Mall P, Chand P, Singh BP , et al. Effectiveness of positioning stents in radiation-induced xerostomia in patients with tongue carcinoma: a randomized controlled trial[J]. Int J Prosthodont, 2016,29(5):455-460.
[33] van der Veen J, Nuyts S . Can intensity-modulated-radiotherapy reduce toxicity in head and neck squamous cell carcinoma[J]. Cancers (Basel), 2017,9(10):E135.
[34] Nutting CM, Morden JP, Harrington KJ , et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial[J]. Lancet Oncol, 2011,12(2):127-136.
[35] Mendenhall WM, Mendenhall CM, Mendenhall NP . Submandibular gland-sparing intensity-modulated radiotherapy[J]. Am J Clin Oncol, 2014,37(5):514-516.
[36] Beetz I, Steenbakkers RJ, Chouvalova O , et al. The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia[J]. Acta Oncol, 2014,53(5):597-604.
[37] Lovelace TL, Fox NF, Sood AJ , et al. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014,117(5):595-607.
[38] Malallah OS, Garcia CMA, Proctor GB , et al. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth)[J]. Int J Pharm, 2018,541(1/2):157-166.
[39] Davies AN, Thompson J. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy[J]. Cochrane Database Syst Rev, 2015(10): CD003782.
[40] Fox NF, Xiao C, Sood AJ , et al. Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2015,120(1):22-28.
[41] Ravi P, Vaishnavi D, Gnanam A , et al. The role of hyperbaric oxygen therapy in the prevention and management of radiation-induced complications of the head and neck—a systematic review of literature[J]. J Stomatol Oral Maxillofac Surg, 2017,118(6):359-362.
[42] Zhuang L, Yang Z, Zeng X , et al. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review[J]. Integr Cancer Ther, 2013,12(3):197-205.
[43] Li LX, Tian G, He J . The standardization of acupuncture treatment for radiation-induced xerostomia: a literature review[J]. Chin J Integr Med, 2016,22(7):549-554.
[44] Lakshman AR, Babu GS, Rao S . Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study[J]. J Cancer Res Ther, 2015,11(1):229-233.
[45] Palma LF, Gonnelli FAS, Marcucci M , et al. Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy[J]. Lasers Med Sci, 2017,32(4):827-832.
[46] Dost F, Farah CS . Stimulating the discussion on saliva substitutes: a clinical perspective[J]. Aust Dent J, 2013,58(1):11-17.
[47] Shiboski CH, Hodgson TA, Ship JA , et al. Management of salivary hypofunction during and after radiotherapy[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103(Suppl): S66.e1-S66.e19.
[1] He Zimu, Li Fenglan. Present application of digital oral positioning stents in radiotherapy of head and neck tumor [J]. Int J Stomatol, 2024, 51(1): 28-35.
[2] Yang Mingyan,Zhang Fan,Zhao Lei. Research progress on oral flora changes affecting the course of radiotherapy and chemotherapy-related oral mucositis [J]. Int J Stomatol, 2023, 50(1): 43-51.
[3] Chen Xiaoli,Zhang Fan,Liu Chengcheng. Application progress on photobiomodulation in the prevention and treatment of oral complications after radiothe-rapy [J]. Int J Stomatol, 2022, 49(6): 707-716.
[4] Li Hongfang,Chen Zhong,Zhang Suxin.. Research progress on immune checkpoint inhibitor combined with radiotherapy in head and neck squamous cell carcinoma [J]. Int J Stomatol, 2022, 49(5): 614-620.
[5] Wei Binbin,Hu Huiwei,Liu Yujuan,Sun Zhe,Yi Yuli. Meta-analysis and GRADE evaluation of the intervention effects of using amifostine before radiotherapy on xerostomia in patients with head and neck cancer [J]. Int J Stomatol, 2020, 47(5): 547-556.
[6] Peng Shuyuan,Xiang Xuerong,Chen Fangchun,Sun Yan,Yin Feng,Li Min. Reliability and validity evaluation of the Chinese version of the oral potentially malignant disorder questionnaire [J]. Int J Stomatol, 2020, 47(5): 557-562.
[7] Shuaihua Qin,Xinming Li,Wenlu Li. Evaluation and correlation analysis of quality of life and coping strategies in patients with symptomatic oral lichen planus [J]. Int J Stomatol, 2019, 46(3): 282-286.
[8] Wei Li,Xiaolin. Nong. Effect and mechanism of diabetes on saliva secretion and salivary glands [J]. Inter J Stomatol, 2018, 45(5): 579-583.
[9] Huang Hanyao, Wang Mengjiao, Wu Hao, Jiang Liping, Zhang Wenjing, Wei Shan, Yin Heng. Reliability and validity of the velopharyngeal insufficiency effects on life outcomes instrument [J]. Inter J Stomatol, 2018, 45(2): 177-184.
[10] Lin Jiu, Yu Fanyuan, Fang Xinyi, Ha Pin, Gong Caixia, Shi Bing. Validation of a Chinese version of oral health-related quality of life in children [J]. Inter J Stomatol, 2017, 44(4): 445-451.
[11] Deng Yuejia1, Wang Chenbing1, Zhang Ximu1, Yue Zhaoguo1, Liu Yunkun1, Jin Zhenning1, Zhao Man2.. Comparison of geriatric oral health assessment index and oral health impact profile-14 as measures of oral healthrelated quality of life of middle-aged and elderly individuals in southwest China [J]. Inter J Stomatol, 2016, 43(6): 632-635.
[12] Liu Pan1, Duolikun?Wufuer1, Cai Zhigang2, Sun Jian3. Clinical significance of serum squamous cell carcinoma antigens in Uyghur patients with oral squamous cell carcinoma [J]. Inter J Stomatol, 2016, 43(6): 645-650.
[13] Wang Lu, Li Xia. Research progress on xerostomia of Sjögren syndrome [J]. Inter J Stomatol, 2016, 43(3): 314-317.
[14] Sun Qiuhua, Xiao Danna, Gao Hui, Dou Zesheng. Correlation between malocclusion and oral health-related life quality in university students [J]. Inter J Stomatol, 2015, 42(2): 156-159.
[15] Lü Danni, Li Ronglin, Yang Guangwei, Li Chunyang. Prevention and treatment of radiation- and chemotherapy-induced oral mucositis [J]. Inter J Stomatol, 2015, 42(2): 177-180.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .